Uncontrolled type 2 diabetes remains a critical health challenge, particularly in underserved populations. Recent studies emphasize that a CGM access pharmacist intervention can significantly bridge the technology gap for these patients. Continuous glucose monitoring (CGM) provides real-time insights, yet financial and logistical hurdles often prevent its use. Consequently, the integration of clinical pharmacists into primary care settings has emerged as a successful strategy to enhance patient outcomes.

Improving Clinical Outcomes via CGM Access Pharmacist Intervention

Pharmacists play a multifaceted role in managing diabetes technology. They assist patients through complex insurance navigation and provide essential hands-on education. Furthermore, pharmacists can interpret glucose data to make timely medication adjustments. Because of their accessible nature, pharmacists serve as a vital link between patients and advanced diabetes care. Additionally, this model has shown to increase the 'Time in Range' (TIR) for patients who previously struggled with traditional finger-stick monitoring. Therefore, pharmacist involvement is key to achieving health equity in diabetes management.

Implementing these services requires a collaborative approach within healthcare teams. Pharmacists can coordinate device distribution and offer troubleshooting support. This reduces the burden on physicians and ensures that technology is utilized effectively. As a result, patients feel more empowered and engaged in their own care. Scaling this model could provide a blueprint for addressing health disparities across diverse clinical settings.

Frequently Asked Questions

How do pharmacists improve access to CGM devices?

Pharmacists facilitate access by navigating payor requirements, managing prior authorizations, and providing direct patient education on device mechanics.

What are the clinical benefits of pharmacist-led CGM programs?

These programs typically lead to improved HbA1c levels, increased time in range, and better medication adherence through personalized data interpretation.

Can this model be applied in resource-limited settings?

Yes, pharmacist-led models are highly scalable and effective in resource-limited communities, helping to mitigate financial and logistical barriers to care.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Refer to the latest local and national guidelines for clinical practice.

References

Pashaeimofrad A et al. Evaluating the role of pharmacist intervention in improving continuous glucose monitor access for patients with uncontrolled diabetes at an FQHC. Am J Health Syst Pharm. 2026 May 28. doi: undefined. PMID: 42207568.

American Diabetes Association. 7. Diabetes Technology: Standards of Care in Diabetes—2024. Diabetes Care. 2024;47(Supplement_1):S126-S144.

Shrestha S et al. Pharmacist-led diabetes mellitus management: A systematic review and meta-analysis of randomized controlled trials. J Clin Pharm Ther. 2022;47(3):303-317.